Actos News
Illinois man files Actos bladder cancer lawsuit
An Illinois man has filed an Actos bladder cancer lawsuit against the manufacturer of the diabetes drug. William Greenlee alleges in his lawsuit that Takeda Pharmaceuticals failed to properly warn patients of the increased risks of bladder cancer when taking Actos for more than a year. More »
Diabetes drugs Byetta, Januvia linked to cancer risk
A new study has found that diabetes patients taking the drugs Januvia or Byetta may be three times more likely to develop pancreatitis or pancreatic cancer. Researchers also discovered a possible increased risk of thyroid cancer among Byetta users. More »
Hissey Kientz Announces the Launch of Actos Bladder Cancer Legal Website
The law firm of Hissey Kientz, LLP is announcing the launch of its new website, Actos Bladder Cancer Lawyers Help. The site will serve as a news and information resource for patients who have been affected by bladder cancer due to the use of Actos. More »
FDA approves new Actos bladder cancer warning
The Food and Drug Administration has approved a new warning about the link between the diabetes drug Actos and bladder cancer. The agency called for the new warning after a study found that patients who use Actos for at least one year are 40% more likely to develop bladder cancer. More »
Diabetes drug Actos tied to increased bladder cancer risk
The Food and Drug Administration has announced the use of the diabetes drug Actos for more than one year can increase a patient’s risk of developing bladder cancer. The agency says that it will add a new warning about the link between Actos and bladder cancer to the drug’s label later this year. More »
New study finds Avandia, Actos fracture risk
A July 2010 study has found that patients taking the diabetes drugs Avandia or Actos may be at an increased risk of bone fractures. According to research published in the Journal of Clinical Endocrinology and Metabolism, Avandia and Actos increased the risk of fractures in postmenopausal women with Type 2 diabetes, as well as in men prescribed either drug plus a loop diuretic. More »
FDA calls for “black-box” Actos warning
The head of the Food and Drug Administration has called for a “black-box” warning to be added to the diabetes drug Actos. The new warning called for by Dr. Andrew von Eschenbach will strengthen the existing warning about Actos side effects, which alerts patients of the risk of congestive heart failure from the drug. He also called for a similar warning on Avandia, another diabetes drug.
FDA knew of Actos side effects risk in 2002
According to a consumer advocacy group, an internal memo from the Food and Drug Administration has revealed that the agency was aware of the risk of Actos side effects as early as July 2002. The memo, released by the group Public Citizen, shows that the FDA did not issue an updated warning for Actos despite knowing of its link with congestive heart failure.
FDA approves new Actos side effects warning
The Food and Drug Administration has approved revised labeling for the diabetes drug Actos. The new labels are designed to warn patients and doctors about the risk of prescribing Actos to patients with uncontrolled diabetes or systolic heart failure.